Skip to content

AdaptDx Selected to be Part of the MACUSTAR Study

Professor Michael Larsen

Professor Michael Larsen from the University of Copenhagen explains the MACUSTAR project, a 5-year study aimed at exploring novel outcome measures for future interventional trials in patients with intermediate AMD. AdaptDx by MacuLogix has been selected as a functional testing device for candidate clinical endpoint development in the study.

Back to Videos